![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2014/11/liver_cancer-300x225.jpg)
Targeting stroma and tumor, silencing galectin 1 treats orthotopic mouse hepatocellular carcinoma
Abstract This study examines inhibiting galectin 1 (Gal1) as a treatment option for hepatocellular carcinoma (HCC). Gal1 has immunosuppressive and cancer-promoting roles. Our data showed that Gal1 was highly expressed in